Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance

BMJ (Online)

Volumn 341, Issue 7763, 2010, Pages 92-94

  Visintin, Cristina ^a   Mugglestone, Moira A ^a   Fields, Ella J ^a   Jacklin, Paul ^a   Murphy, M Stephen ^a,b,c   Pollard, Andrew J ^d  

^a National Collaborating Centre for Women's and Children's Health   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CEFOTAXIME; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; DEXAMETHASONE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

BACTERIAL MENINGITIS; BACTERIUM CULTURE; FLUID RESUSCITATION; HUMAN; LUMBAR PUNCTURE; MENINGOCOCCEMIA; MORBIDITY; MORTALITY; NICE GUIDANCE; PETECHIAL RASH; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SHORT SURVEY; SYMPTOMATOLOGY; ADOLESCENT; ARTICLE; BACTEREMIA; CHILD; DRUG CONTRAINDICATION; EPIDEMIC MENINGITIS; FLUID THERAPY; INFANT; LONG TERM CARE; PRESCHOOL CHILD; PUNCTURE; RISK FACTOR;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FLUID THERAPY; HUMANS; INFANT; LONG-TERM CARE; MENINGITIS, BACTERIAL; MENINGITIS, MENINGOCOCCAL; RISK FACTORS; SPINAL PUNCTURE;

EID: 77954616695     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3209     Document Type: Short Survey

References (10)

1. National Institute for Health and Clinical Excellence. Bacterial meningitis and meningococcal septicaemia: management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. (Clinical guideline 102.) 2010. www.nice.org.uk/CG102.
2. Medicines and Healthcare products Regulatory Agency. Drug safety update. Vol 3, issue 3. 2009. www.mhra.gov.uk/Publications/Safetyguidance/ DrugSafetyUpdate/CON059804.
3. National Institute for Health and Clinical Excellence. Cochlear implants for children and adults with severe to profound deafness. (Technology appraisal 166.) 2009. www.nice.org.uk/TA166.
4. Holt DE, Halket S, de Louvois J, Harvey D. Neonatal meningitis in England and Wales: 10 years on. Arch Dis Childhood Fetal Neonatal Ed 2001;84:F85-9.[CrossRef]
5. Perrett KP, Pollard AJ. Towards an improved serogroup B Neisseria meningitidis vaccine. Expert Opin Biol Ther 2005;5:1611-25.[CrossRef][Web of Science][Medline]
6. Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997;7:R49-54.[Medline]
7. Health Protection Agency. Meningococcus Forum. Guidance for public health management of meningococcal disease in the UK. 2006. www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1194947389261.
8. Office of Public SectorInformation. Health Protection (Notification) Regulations 2010. www.opsi.gov.uk/si/si2010/uksi-20100659-en-1.
9. Department of Health. Health Protection Legislation Guidance 2010. 2010. www.dh.gov.uk/en /Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-114510.
10. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. (Clinical guideline 33.) 2006. www.nice.org.uk/CG33.